RT info:eu-repo/semantics/bachelorThesis
T1 Medicamentos de terapia avanzada: clasificación, reglamentación y perspectivas.
A1 Felipe Morales, Kelsey
K1 Medicamentos de terapia avanzada.
AB Advanced therapy drugs presume the beginning of new ways to solve certainpathologies which does not have effective treatments established properly.The development of these new medicines is based on the use of gene therapy, somaticcell and tissue or tissue engineering. It provides future perspectives regarding theregeneration of skin in burned people, cancer or muscular dystrophy.The authorization is carried out by the Committee for Advanced Therapies at theEuropean Medicines Agency (EMA) which applies to the procedure the establishedguidelines in the legislative framework, whose journey goes back to the establishmentof the same, for the first time in the European Regulation 1394/2007.Furthermore, apart from those already marketed there are six of these products whichare in the process to be definitively authorized but are yet, in a stage of development,or approved but not extended equally.In the European Union, eight advanced therapy medicines have been found under thecentralized marketing authorization.The current trend shunts in enhancing the application of these therapies so that thepatient health is not compromised; such as the economic drug perspective of this field,being the fundamental innovation of the whole procedure.
YR 2019
FD 2019
LK http://riull.ull.es/xmlui/handle/915/17525
UL http://riull.ull.es/xmlui/handle/915/17525
LA es
DS Repositorio institucional de la Universidad de La Laguna
RD 20-abr-2024